URSO, Luca
 Distribuzione geografica
Continente #
NA - Nord America 535
AS - Asia 362
EU - Europa 296
SA - Sud America 8
OC - Oceania 4
AF - Africa 2
Totale 1.207
Nazione #
US - Stati Uniti d'America 524
SG - Singapore 207
IT - Italia 170
CN - Cina 51
ID - Indonesia 45
DE - Germania 35
FI - Finlandia 30
GB - Regno Unito 25
IN - India 14
VN - Vietnam 12
CA - Canada 11
BE - Belgio 9
HK - Hong Kong 8
TH - Thailandia 8
SE - Svezia 7
CZ - Repubblica Ceca 5
IR - Iran 5
KR - Corea 5
LT - Lituania 5
AU - Australia 4
BR - Brasile 4
NL - Olanda 4
AR - Argentina 2
CO - Colombia 2
EG - Egitto 2
MY - Malesia 2
RO - Romania 2
TR - Turchia 2
AT - Austria 1
ES - Italia 1
JP - Giappone 1
PH - Filippine 1
PT - Portogallo 1
RU - Federazione Russa 1
TW - Taiwan 1
Totale 1.207
Città #
Singapore 165
Santa Clara 139
Chandler 60
Jakarta 45
Shanghai 36
New York 30
Milan 27
Ashburn 25
Ferrara 22
Helsinki 20
Fairfield 18
Munich 14
Bologna 13
Dong Ket 12
London 12
Los Angeles 12
Frankfurt am Main 11
Houston 10
Lappeenranta 10
Boardman 8
Buriram 8
Hong Kong 8
Parma 8
Brussels 7
Wilmington 7
Cambridge 6
Ferrara di Monte Baldo 6
Princeton 6
Toronto 6
Bremen 5
Brno 5
Ottawa 5
Poggio Renatico 5
San Diego 5
Woodbridge 5
Lizzano in Belvedere 4
Rovigo 4
Seattle 4
Sydney 4
Addison 3
Ann Arbor 3
Chicago 3
Copparo 3
Florence 3
Hounslow 3
Isfahan 3
Kochi 3
Alpharetta 2
Brasília 2
Cairo 2
Chandigarh 2
Cipolletti 2
Dej 2
Forlì 2
Incheon 2
Istanbul 2
Knoxville 2
Kuala Lumpur 2
Maglie 2
Medellín 2
Molfetta 2
Occhiobello 2
Padova 2
Pelotas 2
Reggio Emilia 2
Sala Baganza 2
Sandston 2
Turnhout 2
Agrate Conturbia 1
Alzano Lombardo 1
Amsterdam 1
Atlanta 1
Barletta 1
Bhubaneswar 1
Cameri 1
Changzhou 1
Cheongju-si 1
Delhi 1
Edison 1
Falls Church 1
Indore 1
Kilburn 1
Leawood 1
Lisbon 1
Madrid 1
Moscow 1
New Bedfont 1
Paderno Dugnano 1
Palermo 1
Pavia 1
Portomaggiore 1
Seodaemun-gu 1
Sona 1
Southwark 1
Stienta 1
Tehran 1
Tokyo 1
Vienna 1
Washington 1
Totale 894
Nome #
177Lu-PRRT in advanced gastrointestinal neuroendocrine tumors: 10-year follow-up of the IRST phase II prospective study 96
90 Y/177 Lu‐dotatoc From Preclinical Studies to Application in Humans 70
Clinical-diagnostic relevance of breast “incidentaloma” detected during 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography: Correlation with radiological imaging and histopathology 58
The Role of [68Ga]PSMA PET/CT for Clinical Suspicion of Prostate Cancer in Patients with or without Previous Negative Biopsy: A Systematic Review 48
Right Atrium Mass Assessed with 18F-FDG PET/CT Scan Turns Out to Be an Uncommon Relapse of Testicular Diffuse Large B-cell Lymphoma: A Case Report 46
Role of PSMA-ligands imaging in Renal Cell Carcinoma management: current status and future perspectives 41
Glucose Metabolism Modification Induced by Radioligand Therapy with [177Lu]Lu/[90Y]Y-DOTATOC in Advanced Neuroendocrine Neoplasms: A Prospective Pilot Study within FENET-2016 Trial 40
18F-Choline PET/CT or PET/MR and the evaluation of response to systemic therapy in prostate cancer: are we ready? 40
Uncommon solitary nasal extramedullary plasmacytoma detected by 18F-FDG PET/CT 38
MONTE CARLO SIMULATIONS IN RADIO-LIGAND THERAPY WITH LU-177 FOR NEUROENDOCRINE TUMOURS (NETS) 37
Considerations on the preliminary results of the NETTER-2 trial: is the glass half full or half empty? 36
Rhenium Radioisotopes for Medicine, a Focus on Production and Applications 34
The Value of Semiquantitative Parameters Derived from 18F-FDG PET/CT for Predicting Response to Neoadjuvant Chemotherapy in a Cohort of Patients with Different Molecular Subtypes of Breast Cancer 33
Radioligand therapy (RLT) as neoadjuvant treatment for inoperable pancreatic neuroendocrine tumors: a literature review 28
Relevance of Volumetric Parameters Applied to [68Ga]Ga-DOTATOC PET/CT in NET Patients Treated with PRRT 28
Role of 18F-FDG PET/CT in evaluating lymph node status in patients with head and neck squamous cell carcinoma 27
FDG PET/CT Volume-Based Quantitative Data and Survival Analysis in Breast Cancer Patients: A Systematic Review of the Literature 26
PET-Derived Radiomics and Artificial Intelligence in Breast Cancer: A Systematic Review 26
The Role of [18F]F-Choline PET/CT in the Initial Management and Outcome Prediction of Prostate Cancer: A Real-World Experience from a Multidisciplinary Approach 24
18F-FDG PET-Derived Volume-Based Parameters to Predict Disease-Free Survival in Patients with Grade III Breast Cancer of Different Molecular Subtypes Candidates to Neoadjuvant Chemotherapy 24
PET Criteria by Cancer Type from Imaging Interpretation to Treatment Response Assessment: Beyond FDG PET Score 23
Superscan-Like Pattern on 18F-Choline PET/CT in a Patient With Essential Thrombocythemia 23
Lutathera® Orphans: State of the Art and Future Application of Radioligand Therapy with 177Lu-DOTATATE 23
[18F]FDG PET-TC radiomics and machine learning in the evaluation of prostate incidental uptake 20
Can Baseline [18F]FDG PET/CT Predict Response to Immunotherapy After 6 Months and Overall Survival in Patients with Lung Cancer or Malignant Melanoma? A Multicenter Retrospective Study 18
COMPARISON BETWEEN CLINICAL DOSIMETRIC PLATFORMS IN NET PATIENTS TREATED WITH PRRT 18
Misinterpretation of an inflammatory FDG uptake in a patient treated for Hodgkin lymphoma: a case report 18
Impact on the long-term prognosis of FDG PET/CT in luminal-A and luminal-B breast cancer 18
Cavernous Hepatic Hemangioma at 18F‑Choline Positron Emission Tomography–Computed Tomography: Be Aware of the Pitfall 17
68Ga-PSMA-11 PET/CT in Bilateral Clear Cell Renal Cell Carcinoma: an Intra-patient Comparison Between High and Low Grade Tumors 17
Incidental findings of acute myeloid leukemia in Sjögren's syndrome detected by nuclear medicine techniques 17
Comparison of MRI vs. [18F]FDG PET/CT for Treatment Response Evaluation of Primary Breast Cancer after Neoadjuvant Chemotherapy: Literature Review and Future Perspectives 17
[18F]-FDHT PET for the Imaging of Androgen Receptor in Prostate and Breast Cancer: A Systematic Review 16
18 F-Choline Versus 68 Ga-PSMA-11 PET/CT Imaging Comparison in Incidental Clear Cell Renal Cell Carcinoma 15
Initial results of the use of a novel semiquantitative parameter in three-phase bone scan to predict 99mTc-HMPAO-labeled leukocyte scintigraphy in patients with unilateral total knee replacement 15
Prognostic factors in children and adolescents with differentiated thyroid carcinoma treated with total thyroidectomy and RAI: a real-life multicentric study 14
99mTc-labeled FAPI compounds for cancer and inflammation: from radiochemistry to the first clinical applications 14
Oldie but Goodie: Is Technetium-99m Still a Treasure Trove of Innovation for Medicine? A Patents Analysis (2000-2022) 13
Advantages of SiPM-based digital PET/CT technology in nuclear medicine clinical practice: a systematic review– part 2 13
ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors 13
Clinical applications of long axial field-of-view PET/CT scanners in oncology 13
ML Models Built Using Clinical Parameters and Radiomic Features Extracted from 18F-Choline PET/CT for the Prediction of Biochemical Recurrence after Metastasis-Directed Therapy in Patients with Oligometastatic Prostate Cancer 13
[99mTc]Tc-sestamibi for the differential diagnosis of renal masses: a study protocol 12
PSMA PET/CT in Castration-Resistant Prostate Cancer: Myth or Reality? 12
PET Radiomics and Response to Immunotherapy in Lung Cancer: A Systematic Review of the Literature 12
Complicated Inguinal Hernia Incidentally Detected on a Radiolabelled Autologous White Blood Cell Scan 12
The Role of Molecular Imaging in Patients with Brain Metastases: A Literature Review 12
Diagnostic Accuracy of PET with 18F-Fluciclovine ([18F]FACBC) in Detecting High-Grade Gliomas: A Systematic Review and Meta-Analysis 12
Diverse Imaging Methods May Influence Long-Term Oncologic Outcomes in Oligorecurrent Prostate Cancer Patients Treated with Metastasis-Directed Therapy (the PRECISE-MDT Study) 11
A Prospective Randomized Multicenter Study on the Impact of [18F]F-Choline PET/CT Versus Conventional Imaging for Staging Intermediate- to High-Risk Prostate Cancer 11
Molecular imaging of PARP in cancer: state-of-the-art 11
The Role of Radiomics in the Era of Immune Checkpoint Inhibitors: A New Protagonist in the Jungle of Response Criteria 10
Hepato-Biliary Imaging in an Acute Setting: Is There a Role for Nuclear Medicine? 9
Is There a Role for FAPI PET in Urological Cancers? 9
Advantages of SiPM-based digital PET/CT technology in nuclear medicine clinical practice: a systematic review—Part 1 oncological setting 9
Lymphoid organs’ metabolism and its role in predicting the outcomes of patients with malignant melanoma treated with immunotherapy: an exploratory study 8
Radiomics and theranostics with molecular and metabolic probes in prostate cancer: toward a personalized approach 7
Extramedullary disease in multiple myeloma: what you might not expect on [18F]FDG PET/CT - a pictorial essay 6
The evolution of PET imaging in renal, bladder, upper urinary tract urothelial, testicular and penile carcinoma - Today's impact, tomorrow's potential 6
Positron Emission Tomography-Derived Radiomics and Artificial Intelligence in Multiple Myeloma: State-of-the-Art 6
The Future Direction of Women in Nuclear Medicine and Nuclear Medicine in Women's Health 5
Phosphorus-32 microparticles for locally advanced pancreatic cancer: how and when? 5
PARP-Targeted Radiotheranostics with Auger Electrons: An Updated Overview 4
The impact of PET imaging on triple negative breast cancer: an updated evidence-based perspective 3
Radioligand therapy in sympathetic-adrenal-medullary axis tumors: state of art and perspectives 3
Totale 1.363
Categoria #
all - tutte 13.267
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.267


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202163 0 0 0 0 1 32 1 5 0 5 1 18
2021/202261 2 0 0 2 5 4 7 2 5 3 15 16
2022/2023186 7 15 3 17 21 20 18 18 14 2 42 9
2023/2024371 11 24 29 14 40 45 12 47 18 12 40 79
2024/2025682 74 87 190 104 227 0 0 0 0 0 0 0
Totale 1.363